All Stories

  1. New Uracil Analogs with Exocyclic Methylidene Group as Potential Anticancer Agents

    Article • Anti-Cancer Agents in Medicinal Chemistry, April 2020, Bentham Science Publishers

    Marek Mirowski, Anna Janecka

  2. The contribution of ABCG2 G34A and C421A polymorphisms to multiple myeloma susceptibility

    Article • OncoTargets and Therapy, February 2019, Dove Medical Press

    Ewa Balcerczak, Marek Mirowski